Blinatumomab in refractory SLE-associated immune thrombocytopenia.

Blincyto (blinatumomab) - Amgen

Blinatumomab in refractory SLE-associated immune thrombocytopenia. (PubMed, Ann Rheum Dis) - Sep 2, 2026 - No abstract available
Journal • Hematological Disorders • Immune Thrombocytopenic Purpura • Inflammatory Arthritis • Thrombocytopenia • Thrombocytopenic Purpura

http://www.ncbi.nlm.nih.gov/pubmed/42680668

Anja Staeck; Anne E Beenken; Antonia Busse; Arnd Kleyer; Arne Sattle; Benedikt Sinzinger; David Simon; Edgar Wiebe; Elpida Phithak; Fredrik N Albach; Gerhard Krönke; Ioanna Minopoulou; Marie Luise Hütter-Krönke; Marie Rehm; Qingyu Cheng; Robert Biesen; Tobias Alexander; Ulrich Keller; Victoria Boeckel

Sep 2, 2026